|1.||Lawnicka, Hanna: 1 article (10/2009)|
|2.||Stepień, Henryk: 1 article (10/2009)|
|3.||Krupiński, Roman: 1 article (10/2009)|
|4.||Stepień, Tomasz: 1 article (10/2009)|
|5.||Siejka, Agnieszka: 1 article (10/2009)|
|6.||Komorowski, Jan: 1 article (10/2009)|
|7.||Sacewicz, Małgorzata: 1 article (10/2009)|
10/01/1991 - "In a single-blind placebo-controlled study, the effect of an iv bolus injection of 100 micrograms GHRH(1-29)NH2 on the response to 200 micrograms TRH was assessed in 10 untreated patients with acromegaly to determine whether GHRH interacts with TRH in acromegaly, as previously described in healthy subjects. "
03/01/1987 - "[Response of growth hormone to GRF(1-29)NH2 in 12 cases of active acromegaly]."
|2.||Body Weight (Weight, Body)
05/01/1996 - "All subjects underwent a GH-RH test (GEREF, Sereno, Rome, Italy) (1 microgram/kg body weight IV). "
01/01/1988 - "Simultaneously, GH secretory responses to single intravenous bolus GRF (1.5 micrograms/kg body weight) were also studied before, during, and 6 months off therapy with GRF(1-29)NH2. "
|3.||Neuroendocrine Tumors (Neuroendocrine Tumor)
01/01/1999 - "Various human cancer cell lines were exposed to human GHRH(1-29)NH2 (2-20 nM) or VIP (0.1-5 nM) repeatedly for 12 min or continuously for 96 min. GHRH antagonist MZ-5-156 at 100 to 200 nM concentration inhibited the GHRH- or VIP-induced cAMP release from mammary (MDA-MB-468), prostatic (PC-3), and pancreatic (SW-1990 and CAPAN-2) cancer cells. "
|5.||Graves Disease (Basedow Disease)
12/01/1992 - "Eight untreated hyperthyroid patients with Graves' disease (6F, 2M, aged 25-50 years) and six healthy volunteers (3F, 3M, aged 27-76 years) underwent from -10 to 30 min in random order: (i) porcine galanin, iv, 500 micrograms in 100 ml saline; or (ii) saline, iv, 100 ml. A bolus of human GHRH(1-29)NH2, 100 micrograms, was injected iv at 0 min. Hyperthyroid patients showed blunted GH peaks after GHRH+saline (10.2 +/- 2.5 micrograms/l) compared to normal subjects (20.7 +/- 4.8 micrograms/l, p < 0.05). "
|1.||Growth Hormone (Somatotropin)
|3.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|5.||Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)